Login/Sign Up
₹19500
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Eribilin Injection 2 ml belongs to a group of medicines known as 'anti-cancer' used to treat various cancers, including breast and liposarcoma. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. Breast cancer is cancer that forms in the cells of the breasts. A liposarcoma is a rare cancer that develops in your fatty tissue.
Eribilin Injection 2 ml contains Eribulin, which works by stopping the cancer cells from separating into two new cells. So, it blocks the growth of the cancer.
Eribilin Injection 2 ml should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. The most common adverse reactions that occur while on therapy are neutropenia (lower-than-normal levels of neutrophils), anaemia (lack of blood), asthenia (weakness), fatigue(tiredness), alopecia (hair loss), peripheral neuropathy (Weakness, numbness, and pain from nerve damage), nausea, and constipation. Most of these side effects of Eribilin Injection 2 ml do not require medical attention and gradually resolve over time. However, if the side effects persist, contact your doctor.
To treat your condition effectually, continue taking Eribilin Injection 2 ml for as long as your doctor has prescribed. Do not stop using the Eribilin Injection 2 ml midway. It is expected to cause fetal harm when administered to a pregnant woman, so it should not be used in pregnant women. Both women and men using this Eribilin Injection 2 ml should use birth control to avoid pregnancy. Discontinue nursing while on therapy, considering the importance of the drug to the mother. Caution should be exercised while using Eribilin Injection 2 ml in patients with hepatic, renal, heart dysfunction and or Neutropenia (Lower-than-normal levels of neutrophils), so inform your doctor about all your medical conditions and medications you are currently taking.
Eribilin Injection 2 ml is used in the treatment of Breast Cancer and Liposarcoma (cancer that develops in your fatty tissue). The detailed uses of Eribilin Injection 2 ml are as follows:
Eribilin Injection 2 ml helps treat certain advanced cancers by slowing the growth and spread of cancer cells. With regular use as prescribed, it helps control disease progression, relieve cancer-related symptoms, and support improved treatment outcomes.
Unsafe
Avoid alcohol consumption while on treatment with Eribilin Injection 2 ml.
Unsafe
Eribilin Injection 2 ml should not be used during pregnancy because it can harm your fetus (newborn baby).
Unsafe
Do not breastfeed during this treatment because the medicine may pass into your milk. Doctors normally advise against breastfeeding throughout this treatment and for a certain period of time after the final medication is taken.
Caution
Eribilin Injection 2 ml may cause side effects such as tiredness and dizziness. Do not drive or use machines if you feel tired or dizzy.
Caution
A lower starting dose is recommended for patients with mild (Child-Pugh A) and moderate (ChildPugh B) liver impairment. There is no information available on patients with severe liver impairment.
Caution
A lower starting dose is recommended for patients with moderate (CrCl 30-50 mL/min) kidney impairment. There is no information available on patients with severe kidney impairment.
Unsafe
Do not use this medicine for children between 0 to 18 years old.
Caution
Eribilin Injection 2 ml may increase the risk of heart problems. Therefore, please consult your doctor if you have any heart-related problems before using Eribilin Injection 2 ml.
Safe if prescribed
Eribilin Injection 2 ml is generally considered safe when used under medical supervision in geriatric patients; however, significant precautions should be taken due to age-related sensitivities.
Have a query?
The time required for Eribilin Injection 2 ml to start to work: The time required for Eribilin Injection 2 ml to show its action is not clinically established. The time for which the effects of Eribilin Injection 2 ml last: The duration of action for Eribilin Injection 2 ml is not clinically established.
Login/Sign Up
No clinically significant food interactions are known with Eribilin Injection 2 ml when used as directed.
Login/Sign Up
Disclaimer
